TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Takeda Pharma AB
Closing information (x1000 DKK)
Closing information | 2024/03 | 2023/03 | 2022/03 |
Turnover |
1,476,503
|
1,359,111
|
1,271,447 |
Financial expenses |
2,143
|
10,495
|
3,184 |
Earnings before taxes |
48,190
|
41,223
|
43,511 |
EBITDA |
50,929
|
46,583
|
45,765 |
Total assets |
574,380
|
513,881
|
514,261 |
Current assets |
571,151
|
510,014
|
506,571 |
Current liabilities |
375,202
|
347,141
|
365,157 |
Equity capital |
197,538
|
164,917
|
146,562 |
- share capital |
1,294
|
1,321
|
1,439 |
Employees (average) |
99
|
101
![]() |
101 |
Financial ratios
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Solvency |
34.4%
|
32.1%
|
28.5% |
Turnover per employee |
14,914
|
13,457
|
12,589 |
Profit as a percentage of turnover |
3.3%
|
3.0%
|
3.4% |
Return on assets (ROA) |
8.8%
|
10.1%
|
9.1% |
Current ratio |
152.2%
|
146.9%
|
138.7% |
Return on equity (ROE) |
24.4%
|
25.0%
|
29.7% |
Change turnover |
145,114
|
191,676
|
-212,629 |
Change turnover % |
11%
|
16%
|
-14% |
Chg. No. of employees |
-2
|
0
|
-11 |
Chg. No. of employees % |
-2%
|
0%
|
-10% |
Total value of public sale
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.